Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Loza

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
The IL-12 signature: NK cell terminal CD56+high stage and effector functionsMatthew J Loza, Bice Perussia
Nature Immunology|September 29, 2001
Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?M J Loza, B Perussia
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2000
Assays for antibody-dependent cell-mediated cytotoxicity (ADCC) and reverse ADCC (redirected cytotoxicity) in human natural killer cellsB Perussia, M J Loza
Methods in Molecular Medicine|October 20, 2004
Purification of peripheral blood natural killer cellsBice Perussia, Matthew J Loza
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine productionMatthew J Loza, Bice Perussia
Trends in Immunology|May 10, 2003
Linear "2-0-1" lymphocyte development: hypotheses on cellular bases for immunityBice Perussia, Matthew J Loza
International Immunology|December 23, 2003
Differential regulation of NK cell proliferation by type I and type II IFNMatthew J Loza, Bice Perussia
European Journal of Immunology|April 3, 2003
Accumulation of type 2 cytokine+ T cells: differentiation-independent proliferation of pre-existing type 2 T cellsMatthew J Loza, Bice Perussia
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|June 14, 2021
The Effect of COVID-19 Pandemic Restrictions on Lead Screening in a Primary Care ClinicAndrew J Loza, Benjamin R Doolittle
Sangre|January 1, 1979
[Acquired granulocyte function impairments (author's transl)]M Giralt, J Loza, I Egurbide
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|December 23, 2003
The IL-12 signature: NK cell terminal CD56+high stage and effector functionsMatthew J Loza, Bice Perussia
Nature Immunology|September 29, 2001
Final steps of natural killer cell maturation: a model for type 1-type 2 differentiation?M J Loza, B Perussia
Methods in Molecular Biology (Clifton, N.J.)|May 20, 2000
Assays for antibody-dependent cell-mediated cytotoxicity (ADCC) and reverse ADCC (redirected cytotoxicity) in human natural killer cellsB Perussia, M J Loza
Methods in Molecular Medicine|October 20, 2004
Purification of peripheral blood natural killer cellsBice Perussia, Matthew J Loza
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2002
Peripheral immature CD2-/low T cell development from type 2 to type 1 cytokine productionMatthew J Loza, Bice Perussia
Trends in Immunology|May 10, 2003
Linear "2-0-1" lymphocyte development: hypotheses on cellular bases for immunityBice Perussia, Matthew J Loza
International Immunology|December 23, 2003
Differential regulation of NK cell proliferation by type I and type II IFNMatthew J Loza, Bice Perussia
European Journal of Immunology|April 3, 2003
Accumulation of type 2 cytokine+ T cells: differentiation-independent proliferation of pre-existing type 2 T cellsMatthew J Loza, Bice Perussia
Journal of Pediatric Health Care : Official Publication of National Association of Pediatric Nurse Associates & Practitioners|June 14, 2021
The Effect of COVID-19 Pandemic Restrictions on Lead Screening in a Primary Care ClinicAndrew J Loza, Benjamin R Doolittle
Sangre|January 1, 1979
[Acquired granulocyte function impairments (author's transl)]M Giralt, J Loza, I Egurbide
Pageof 12